Dr. Reddy’s Laboratories launches antimuscarinic drug Toviaz generic in US
Dr. Reddy’s Laboratories has launched Dr. Reddy’s Fesoterodine Fumarate Extended-Release Tablets in the US market following the approval of the US Food and Drug Administration (FDA).
The product is generic of Toviaz (fesoterodine fumarate) Extended-Release Tablets of Pfizer, an antimuscarinic drug used for the treatment of certain bladder problems.
Dr. Reddy’s Laboratories launches antimuscarinic drug Toviaz generic in US. Photo courtesy of Karthikndr/Wikimedia Commons.
According to IQVIA, the Toviaz brand had sales of nearly $211 million MAT in the US for the most recent 12 months ending in May 2022.
Dr. Reddy’s Fesoterodine Fumarate Extended-Release Tablets come in 4mg and 8mg tablets, each in bottle count sizes of 30.
Related Posts
CATEGORIES Pharma Industry News